Search - tctmd.com

Displaying 241 - 260 of 271

Sort: Relevancy | Date

News Conference News Cell Therapy 2012

Novel Strategies Advance Cell Therapy for Cardiomyopathy

February 05, 2012

News Conference News

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

November 13, 2011

News Industry News

Elixir Medical Announces DESolve Nx International Pivotal Trial Initiation for Fully Bioresorbable Coronary Scaffold System

November 10, 2011

News Industry News

Hansen Medical's Magellan(TM) Robotic System to Be Presented at International Symposium

November 09, 2011

News Industry News

Bayer cooperates with Ludwig Boltzmann Institute for Translational Heart Failure Research

November 08, 2011

News Industry News

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care

November 08, 2011

News Industry News

Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial

November 08, 2011

News Industry News

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

November 04, 2011

News Industry News

Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance® Drug Eluting Balloon with Paccocath® Technology to be Presented at 2011 TCT

November 03, 2011

News Daily News

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

L.A. McKeown

November 01, 2011

News Daily News

FDA, CMS Parallel Review Aims to Speed Access to Innovative Technologies

L.A. McKeown

October 14, 2011

News Daily News

TAVR Travelers: Medical Tourism Gaining Ground

L.A. McKeown

September 26, 2011

News Industry News

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

September 08, 2011

News Industry News

Enrollment at St. John's Hospital Marks Official Start of the Largest Randomized Peripheral Drug-Coated Balloon Trial To Date

July 25, 2011

News Daily News

FDA Panel Recommends Approval of Transcatheter Heart Valve

July 21, 2011

News Industry News

FDA Panel Recommends Approval of Edwards Transcatheter Valve for Treatment of Inoperable Patients

July 20, 2011

News Daily News

Smaller Delivery System Means Fewer Complications with Aortic Valve Implantation

L.A. McKeown

July 19, 2011

News Daily News

BARC: New Bleeding Definitions Aim to Standardize Trial Endpoints

L.A. McKeown

June 17, 2011

News Industry News

FDA Advisory Panel to Review Edwards SAPIEN Valve on July 20

June 07, 2011

News Daily News

Canada Approves Ticagrelor in ACS Patients

June 02, 2011

Advertisement

Novel Strategies Advance Cell Therapy for Cardiomyopathy

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

Elixir Medical Announces DESolve Nx International Pivotal Trial Initiation for Fully Bioresorbable Coronary Scaffold System

Hansen Medical's Magellan(TM) Robotic System to Be Presented at International Symposium

Bayer cooperates with Ludwig Boltzmann Institute for Translational Heart Failure Research

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care

Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance® Drug Eluting Balloon with Paccocath® Technology to be Presented at 2011 TCT

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

FDA, CMS Parallel Review Aims to Speed Access to Innovative Technologies

TAVR Travelers: Medical Tourism Gaining Ground

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

Enrollment at St. John's Hospital Marks Official Start of the Largest Randomized Peripheral Drug-Coated Balloon Trial To Date

FDA Panel Recommends Approval of Transcatheter Heart Valve

FDA Panel Recommends Approval of Edwards Transcatheter Valve for Treatment of Inoperable Patients

Smaller Delivery System Means Fewer Complications with Aortic Valve Implantation

BARC: New Bleeding Definitions Aim to Standardize Trial Endpoints

FDA Advisory Panel to Review Edwards SAPIEN Valve on July 20

Canada Approves Ticagrelor in ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content